Boyu Capital and Portfolio Companies Recognized in PharmCube’s 2025 China Innovative Drug Annual List and VB100’s 2026 Future Healthcare Top 100 Series
NewMed
Artificial Heart Valve System Developer
Haihe Biopharma
Developer of Innovative Anti-Tumor Drugs
MediTrust Health
Innovative Inclusive Health Medical Service and Security Platform
Click AboveBlue TextFollow Us
Today, the PharmaCube 2025 Annual Rankings and the VB2026 Future Healthcare 100 Strong series rankings have been officially released.
Boyu Capital Honored with:
PharmaCube·2025 Annual Rankings
"TOP 15 Venture Capital Institutions in China's Innovative Drug Industry"
Artery Network·2026 Future Healthcare 100 Strong Series Rankings
"Top 50 in China's Healthcare Industry – Value Investment and Service Institutions"
Chen Penghui, Founding Partner of Boyuan Capital, Honored with:
Arterial Network·2026 Future Healthcare 100 Strong Series Rankings
"Top 50 Influential Figures in China's Healthcare Industry—Innovation Impact"
Multiple portfolio companies of Boyuan Capital have been honored with awards:
PharmaCube·2025 Annual Rankings
"Top 15 Emerging Innovative Pharmaceutical Companies"
"Top 15 High-Quality Frontier Innovation Achievements in China's Innovative Drug Industry"
Arterial Network·2026 Future Healthcare 100 Strong Series Rankings
The award-winning situation is as follows:
MedCube
Top 15 Venture Capital Institutions in China's Innovative Drug Sector for 2025
Arterial Network·2026 Future Healthcare 100 Strong
China Healthcare Industry
Top 50 in Value Investment and Service Institutions
Artery Network·2026 Future Healthcare 100 Strong
China Healthcare Industry
Top 50 Innovators
MedCube
Top 15 Emerging Innovative Pharmaceutical Companies in China for 2025
PharmaCube
Top 15 High-Quality Frontier Innovation Achievements in China's Innovative Drug Sector for 2025
Artery Network · 2026 Future Healthcare 100 Strong
Top 100 List of Innovative Devices and Intelligent Manufacturing
NewMed, Huihe Medical, HaiJieYa
Qianglian Zhichuang, Shenluo Medical, Sailu
Far Mountain Medical, Care Group, Ruijing Bio
HaiHe Biopharma, AnYiPu
Artery Network·2026 Future Healthcare 100 Strong
Top 100 in Innovative Pharmaceuticals and Biologics
HaiHe Biopharma, Ark Biosciences, ZhenBio
Kangrun Bio, Minghui Pharma, Zhitai Bio
Daru Biotech, Zhongsheng Traceability, Ruifeng Biotech
Beqi Bio, SuprRay
Artery Network · 2026 Future Healthcare 100 Strong
Top 100 in Innovative Health Services and Industrial Chain Services
MediTrust Health, Yizhun Intelligence, Huimei Data Technology
GenoArray Biotech, Huapu Science Instruments, Square and
Artery Network · China Healthcare Industry
Top 50 Enterprises with the Most Investment Value
Listed Company: Changfeng Pharmaceuticals
Non-listed companies: HaiHe Biopharma, MediTrust Health
Artery Network · China Healthcare Industry
Top 50 Most Innovative Product Technologies
Intelligent Medical Device Technology:
Intelligent Medical Device Technology:
Qianglian Zhichuang - AI Catheter Shaping Robot
ShenNerve Medical-Spinal Cord Stimulator (SCS)
Biotechnology:
Zhongsheng溯源-NCR201 Injection
Artery Network · 2026 Healthcare
Top 50 List of Innovative Strength Among Listed Companies
Silver诺Pharmaceuticals
HaiHe Biopharma
Previous Recommendations
